Absorption pathway refers to the route a compound takes from the skin surface into living tissue. For most peptides, the route ends quickly, blocked at the outermost layer. copper peptide ghk-cu moves further than most because it is built from only three amino acids, small enough to slip through defences that stop bulkier molecules. What follows traces its full journey, from first contact through to its final resting point in the dermis.
Topical barrier crossing
Barrier crossing is the opening stage, and the stratum corneum decides who gets through. This layer of flattened dead cells rejects most applied compounds outright. GHK-Cu qualifies for passage on weight alone. At roughly 340 daltons in free form, it falls well under the 500 dalton ceiling that skin permeation research treats as the practical cutoff. Passage happens along the lipid matrix between corneocytes. The complex rarely moves through cells directly because its partial charge resists that route. That same charge slows diffusion overall, which is why formulators adjust pH or add penetration enhancers to keep uptake steady. Skin model testing puts numbers behind this. Within hours of application, measurable peptide appears in the viable epidermis, carried almost entirely through those intercellular lipid channels.
Follicular absorption channel
Follicular openings hand the peptide a shortcut. Follicles are basically open shafts running deep into the dermis, lined with tissue much thinner than surface skin, and they welcome small molecules otherwise queued at the barrier. Permeation work on follicle dense regions shows peptide gathering around these openings at concentrations that flat skin never matches, and the depth reached through a single shaft exceeds anything surface diffusion achieves in the same period. Scalp tissue illustrates the effect best. Comparative testing finds it absorbs the complex faster than facial or body skin, purely because follicles crowd it so densely. One practical detail shapes outcomes here. Sebum filling the shaft slows entry, so freshly cleansed skin takes up the peptide more readily than skin carrying a full oil load. Researchers studying hair growth pay close attention to this channel, since it delivers the compound directly beside the stem cells governing follicle cycles.
Dermal anchoring stage
Dermal anchoring closes the pathway. Once the peptide arrives in the dermis, forward movement stops and binding takes over. GHK-Cu attaches firmly to extracellular matrix structures, collagen fragments and glycosaminoglycans, among them, rather than washing onward into circulation. Anchored this way, it sits exactly where fibroblasts operate. Copper leaves the complex slowly from this position. A variety of copper-dependent enzymes and transport proteins dissolve copper when needed, supplying lysyl oxidase and superoxide dismutase. The bare GHK fragment left behind is not spent either. It continues signalling through cell receptors on its own. It has been found through radiolabeled tracking that the complex remains detectable even after one application to animal skin, unlike the common belief that it is rapidly washed away from the skin after application.
In order for copper peptide GHK-Cu to achieve topical effects, it goes through three stages, each based on a different characteristic. Despite its small size, the molecule has the ability to pass through the stratum corneum, follicle shafts are open, allowing it to travel deep into the follicles, and matrix affinity allows it to stay in place while copper is transported to working enzymes. Together, these determine how much of an applied dose ends up active in living skin.